CRISPR technology allows researchers to illuminate and monitor alpha synuclein in the brain.
A new study confirms a mutation caused dysfunction associated with Alzheimer's and proposes a new therapeutic target.
Researchers have developed a new method to accurately and rapidly locate proteins within brain cells.
